The Psychedelic Investment Opportunity: Separating the Posers from the Pioneers
Psilocybin, ketamine, MDMA, LSD and mescaline are creating a new paradigm in wellbeing, and investors are taking notice. With the inflection point for psychedelic science here, savvy investors are eager to weed out the posers from the pioneers, particularly given the rapid rate at which the regulatory landscape, cultural attitudes and research are evolving. But, fear not. We’ve assembled some of the brightest financial minds from across the psychedelic ecosystem to help you easily distinguish get-rich-quick schemes from actionable investment opportunities.